logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
18/09/2026
The central bank today conducted a 7-day reverse repurchase operation of 463.3 billion yuan through fixed-rate, quantity-based bidding, fully meeting the demand of primary dealers. At the same time, it conducted a 14-day reverse repurchase operation of 100 billion yuan through fixed-quantity, rate-based bidding with multiple-price awards.
Latest
3 m ago
Oil price decline and the Federal Reserve's rate hike "cool down" inflation panic, gold regains its footing above the 100-day moving average.
5 m ago
Hong Kong Stock Movement | Hengrui Pharmaceuticals (01276.HK) rises nearly 4%; the company repurchases A-shares for the first time; institutions are bullish that the non-oncology segment will continue to contribute product-side incremental growth.
6 m ago
HK Stock Movement | Xuanzhu Biopharm-B (02575.HK) rose over 7% in early trading; the company issued a clarification announcement, disclosing that it is in negotiations regarding a potential acquisition.
7 m ago
HK Stock Movement | IMPACT Therapeutics-B (07630.HK) Surges Over 25% in Early Trading; Recently Included in Stock Connect and Received Executive Shareholding Increase; Core Product Senaparib Accelerates Sales Growth
8 m ago
Morgan Stanley: Kingboard Laminates (01888.HK) rated "Overweight" with a target price of HK$75
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.